u/camila_marchand

the language barrier is a real cost and nobody budgets for it

Reimbursed or private?

keep every letter, the dates matter later

NHS pathway or private prescription?

Do you have a written baseline from before you started changing anything?

Correction: that threshold is your ICB’s, not a national one. They differ and they change by year.

That reads as a warning about a documented supplier and the events you describe are about a shop nobody has any record of.

Cosigning on discharge at goal.

Agreed — and keeping the letters with dates is what makes any later challenge possible.

The online consultation asked me three questions, none of them about my history.

This is why national advice does not work here. It is commissioned locally and it varies.

Told everybody, then stopped, then had to tell everybody that too. That was harder than any of the rest of it.

stopping is a plan, not an event

stopping abruptly and stopping gradually are different experiences

Lost money to a shop that had nothing verifiable on file anywhere. Posting so that somebody searching that name finds this.

specialist service, not GP, for tier 3 in most of England

That is the first-month offer price, not the ongoing monthly cost. The tracker records the second one.

Not convinced that was avoidable. Some of this is genuinely bad luck and treating everything as a lesson is its own trap.

Is that a weight number from a different programme?

That figure is from the obesity programme, and this thread is about the hepatic one.

read the histology endpoint definitions before quoting a response rate

the EMA authorises, member states decide who pays

the MHRA supply notices are published, read them before the panic threads

Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.

That is the controversial ordering, not the hot one. Different formula, different behaviour.

modmail first, always, and the thread second

Cosigning that cost and supply are legitimate reasons. Most of the stopping threads here are one of those two.

Spent my first fortnight comparing myself to the loudest posters. Do not do that; they are not the middle of the distribution.

The escalation schedules in the published protocols are slow and deliberate, and the tolerability tables show why. That is a description of the trials rather than a suggestion for anybody.

Disagree with the framing. Regain is the documented outcome after discontinuation; calling it a personal failure is both wrong and corrosive.

Agreed — somebody is at exactly the point you were at, reading this, and it will land differently for them than any success story.

discharge at goal back to the GP is where a lot of people fall over

That figure is from the obesity programme, and this thread is about the hepatic one.

Which pharmacy, and what did they quote for the month rather than the first month?

Sent a vial to VendorInvestigate because there was nothing on file. 97.9% against a claimed 97.0%. First entry for this compound in my own log.

money lost to a shop with nothing on file is the recurring story

Wrote the concentration on the vial after reading it here. Have never once had to reconstruct it from memory since.

It is a dual agonist at the GLP-1 and glucagon receptors. The glucagon arm is associated with increased energy expenditure and with effects on hepatic fat, which is why the development programme is oriented towards liver disease.